These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38298080)

  • 1. Methamphetamine-Induced Psychosis and Schizophrenia: A Call for Special Attention: Response to Zhu et al.
    Rognli EB; Høye A; Bramness JG
    Am J Psychiatry; 2024 Feb; 181(2):168-169. PubMed ID: 38298080
    [No Abstract]   [Full Text] [Related]  

  • 2. First psychotic episode risk markers for primary psychosis amongst people who use methamphetamine.
    McKetin R; Hides L; Kavanagh DJ; Saunders JB; Dawe S
    Schizophr Res; 2018 Sep; 199():456-457. PubMed ID: 29680188
    [No Abstract]   [Full Text] [Related]  

  • 3. Methamphetamine-Induced Psychosis and Schizophrenia: A Call for Special Attention.
    Zhu L; Ni T; Guan F
    Am J Psychiatry; 2024 Feb; 181(2):168. PubMed ID: 38298079
    [No Abstract]   [Full Text] [Related]  

  • 4. Methamphetamine-associated psychosis: links to drug use characteristics and similarity to primary psychosis.
    Yang M; Yang C; Liu T; London ED
    Int J Psychiatry Clin Pract; 2020 Mar; 24(1):31-37. PubMed ID: 31609149
    [No Abstract]   [Full Text] [Related]  

  • 5. Remission of persistent methamphetamine-induced psychosis after cariprazine therapy: presentation of a case report.
    Ricci V; Di Salvo G; Maina G
    J Addict Dis; 2022; 40(1):145-148. PubMed ID: 34180372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Amphetamine-induced psychosis or schizophrenia?].
    Rognli EB; Medhus SE; Bramness JG
    Tidsskr Nor Laegeforen; 2015 Feb; 135(3):249-51. PubMed ID: 25668544
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter to the Editor-Is Chronic Methamphetamine-Induced Psychosis A Mental Disease for the Purposes of Insanity?
    Reisner AD; Piel JL
    J Forensic Sci; 2020 Jul; 65(4):1382-1383. PubMed ID: 32396213
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuropsychiatric Adverse Effects of Amphetamine and Methamphetamine.
    Harro J
    Int Rev Neurobiol; 2015; 120():179-204. PubMed ID: 26070758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methamphetamine Use and Antipsychotic-related Extrapyramidal Side-effects in Patients with Psychotic Disorders.
    Temmingh HS; van den Brink W; Howells F; Sibeko G; Stein DJ
    J Dual Diagn; 2020; 16(2):208-217. PubMed ID: 31984872
    [No Abstract]   [Full Text] [Related]  

  • 10. Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders.
    McKetin R; Baker AL; Dawe S; Voce A; Lubman DI
    Psychiatry Res; 2017 May; 251():349-354. PubMed ID: 28282630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methamphetamine psychosis: insights from the past.
    McKetin R
    Addiction; 2018 Aug; 113(8):1522-1527. PubMed ID: 29516555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic psychotic illness from methamphetamine.
    Buffenstein A; Heaster J; Ko P
    Am J Psychiatry; 1999 Apr; 156(4):662. PubMed ID: 10200757
    [No Abstract]   [Full Text] [Related]  

  • 13. A systematic review of risk factors for methamphetamine-associated psychosis.
    Arunogiri S; Foulds JA; McKetin R; Lubman DI
    Aust N Z J Psychiatry; 2018 Jun; 52(6):514-529. PubMed ID: 29338289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosis induced by amphetamines.
    Bramness JG; Rognli EB
    Curr Opin Psychiatry; 2016 Jul; 29(4):236-41. PubMed ID: 27175554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application Prospect of Integrative Omics in Forensic Identification of Methamphetamine-Associated Psychosis.
    Zhao LR; Zhang JB; Han W; Zhu L; Chen T; Guan FL
    Fa Yi Xue Za Zhi; 2022 Oct; 38(5):650-656. PubMed ID: 36727182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methamphetamine use and psychotic symptoms: findings from a New Zealand longitudinal birth cohort.
    Boden JM; Foulds JA; Newton-Howes G; McKetin R
    Psychol Med; 2023 Feb; 53(3):987-994. PubMed ID: 34134802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature.
    Grelotti DJ; Kanayama G; Pope HG
    Am J Psychiatry; 2010 Jan; 167(1):17-23. PubMed ID: 20068123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing prefrontal cortical activity during inhibition task in methamphetamine-associated psychosis versus schizophrenia: a multi-channel near-infrared spectroscopy study.
    Okada N; Takahashi K; Nishimura Y; Koike S; Ishii-Takahashi A; Sakakibara E; Satomura Y; Kinoshita A; Takizawa R; Kawasaki S; Nakakita M; Ohtani T; Okazaki Y; Kasai K
    Addict Biol; 2016 Mar; 21(2):489-503. PubMed ID: 25619621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vigilance needed with methamphetamine-associated psychosis.
    Elefante RJO; Nolan S; Bach PJ
    CMAJ; 2023 Oct; 195(39):E1356. PubMed ID: 37816525
    [No Abstract]   [Full Text] [Related]  

  • 20. Subcortical grey matter alterations in cocaine dependent individuals with substance-induced psychosis compared to non-psychotic cocaine users.
    Willi TS; Lang DJ; Honer WG; Smith GN; Thornton AE; Panenka WJ; Procyshyn RM; Vila-Rodriguez F; Su W; Vertinsky AT; Leonova O; Rauscher A; MacEwan GW; Barr AM
    Schizophr Res; 2016 Oct; 176(2-3):158-163. PubMed ID: 27499362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.